Synapse - Myeloma

Results (990)

Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosis

Meeting Abstract

Landau, H.; Hassoun, H.; Bello, C.; Hoover, E.; Jia, X.; Riedel, E. R.; Nimer, S. D.; Comenzo, R. L.
Amyloid (2010)

Fulltext@MSK | Save

Pathobiologic associations of plasma cell (PC) overexpression of Cyclin D1 (CCND1) in systemic AL amyloidosis (AL)

Meeting Abstract

Comenzo, R. L.; Hoffman, J. E.; Hassoun, H.; Landau, H.; Iyer, L.; Zhou, P.
Amyloid (2010)

Fulltext@MSK | Save

Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs

Journal Article

Nakahara, T.; Uchi, H.; Lesokhin, A. M.; Avogadri, F.; Rizzuto, G. A.; Hirschhorn-Cymerman, D.; Panageas, K. S.; Merghoub, T.; Wolchok, J. D.; Houghton, A. N.
Blood (2010)

Fulltext@MSK | Save

FDG PET/CT (FDG PET) in evaluation of response in patients with multiple myeloma (MM) treated with bortezomib, pegylated liposomal doxorubicin, and dexamethasone

Meeting Abstract

Pandit-Taskar, N.; Comenzo, R. L.; Hassoun, H.; Hoover, E.; Borkar, S.; Reidel, E.; Cohen, A.; Surti, C.; Nimer, S. D.; Landau, H. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in patients with light-chain amyloidosis (AL)

Meeting Abstract

Landau, H. J.; Hoffman, J.; Hassoun, H.; Elizabeth, H.; Riedel, E.; Nimer, S. D.; Cohen, A.; Comenzo, R. L.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Elevated cyclin D1 (CCND1) expression in the plasma cells of patients with systemic AL amyloidosis at diagnosis is associated with higher brain natriuretic peptide (BNP) levels, increased plasma cells and significantly poorer survival

Meeting Abstract

Zhou, P.; Hoffman, J. E.; Hassoun, H.; Landau, H.; Comenzo, R. L.
Blood (2009)

Fulltext@MSK | Save

Phase III intergroup study of lenalidomide (CC-5013) versus placebo maintenance therapy following single autologous stem cell transplant for multiple myeloma (CALGB 100104): Initial report of patient accrual and adverse events

Meeting Abstract

McCarthy, P. L.; Owzar, K.; Stadtmauer, E. A.; Giralt, S.; Hurd, D. D.; Hassoun, H.; Hofmeister, C.; Richardson, P.; Weisdorf, D. J.; Pasquini, M. C.; more...
Blood (2009)

Fulltext@MSK | Save

Treatment of heparin-induced thrombocytopenia and associated thromboses with fondaparinux

Meeting Abstract

Chan, A.; Egan, D.; Landau, H.; Hassoun, H.
Blood (2009)

Fulltext@MSK | Save

Outcome of patients with multiple myeloma treated with autologous stem cell transplantation in the era of novel therapies

Meeting Abstract

Hassoun, H.; Landau, H.; Surti, C.; Adel, N. G.; Jia, X. Y.; Riedel, E. R.; Manisha, B.; Comenzo, R.; Lesokhin, A.; Chung, D. J.; more...
Blood (2009)

Fulltext@MSK | Save

Cisplatin-based chemotherapy is associated with an unacceptably high incidence of thromboembolic events: A large retrospective analysis

Meeting Abstract

Moore, R. A.; Adel, N. G.; Bhutani, M.; Tabbara, N. E.; Landau, H.; Nimer, S. D.; Feldman, D. R.; Hassoun, H.
Blood (2009)

Fulltext@MSK | Save